Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

DarioHealth (DRIO) Invested Capital (2016 - 2025)

DarioHealth filings provide 14 years of Invested Capital readings, the most recent being $67.9 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 12.32% to $67.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.9 million, a 12.32% decrease, with the full-year FY2025 number at $67.9 million, down 12.32% from a year prior.
  • Invested Capital hit $67.9 million in Q4 2025 for DarioHealth, down from $74.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $118.1 million in Q2 2021 to a low of $62.1 million in Q4 2023.
  • Median Invested Capital over the past 5 years was $81.3 million (2023), compared with a mean of $84.8 million.
  • Biggest five-year swings in Invested Capital: soared 866.08% in 2021 and later tumbled 30.09% in 2023.
  • DarioHealth's Invested Capital stood at $85.5 million in 2021, then increased by 3.83% to $88.8 million in 2022, then tumbled by 30.09% to $62.1 million in 2023, then rose by 24.75% to $77.5 million in 2024, then decreased by 12.32% to $67.9 million in 2025.
  • The last three reported values for Invested Capital were $67.9 million (Q4 2025), $74.9 million (Q3 2025), and $64.0 million (Q2 2025) per Business Quant data.